GLP1R and obesity due to melanocortin 4 receptor deficiency: On the other hand, glucagon-like peptide-1 receptor agonists (GLP-1RAs) represent a newer group of medications used to treat obesity, showing significant potential in supporting weight loss for individuals struggling with this condition [3].